Login
$XBIO
$1.85 +$0.13 (7.56%) Close

$XBIO 3 SEC Filings

Filed On Filing
18 Dec 2023 Form 3: Mizrahy Moshe, Director

Holds 0 shares of Common Stock

30 Sep 2019 Form 3: Borisenko Grigory G., Director

No securities owned

05 Aug 2019 Form 3: Vinogradov Alexey Andreevich, Director

Holds 186,781 shares of Common Stock

27 Oct 2017 Form 3: Llc Synbio, 10% owner

Holds 821,567 shares of Common Stock

27 Oct 2017 Form 3: Pjsc Pharmsynthez, 10% owner

Holds 4,544,488 shares of Common Stock

12 Sep 2017 Form 3: Genkin Dmitry, Director

Holds 32,000 shares of Common Stock

29 Aug 2017 Form 3: Callaway James Eric, Director

Holds 0 shares of Common Stock

22 Aug 2017 Form 3: Logal Adam, Director

Holds 0 shares of Common Stock

04 Apr 2017 Form 3: Parslow James F, Chief Financial Officer

No securities owned

06 Jan 2017 Form 3: Lockshin Curtis, Chief Scientific Officer
30 Nov 2016 Form 3: Benz Edward J. Jr, Director

Holds 0 shares of Common Stock

22 Nov 2016 Form 3: Maguire Michael Scott, Director

Holds 73,953 shares of Common Stock

21 Nov 2016 Form 3: Dastoor Firdaus J., Director
21 Nov 2016 Form 3: Kornberg Roger D., Director

Holds 0 shares of Common Stock

21 Nov 2016 Form 3: Knyazev Roman, Director
15 Nov 2016 Form 3: Deptula-hicks Darlene M, Director
15 Nov 2016 Form 3: Eisenberg Jeffrey F, Director

Holds 0 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support